Genome-wide association analysis identifies common variants influencing infant brain volumes

Translational Psychiatry

Volumn 7, Issue 8, 2017, Pages

  Xia, K ^a   Zhang, J ^b   Ahn, M ^b,g   Jha, S ^c   Crowley, J J ^a,d   Szatkiewicz, J ^a   Li, T ^e   Zou, F ^b,h   Zhu, H ^b,e   Hibar, D ^f,i   Thompson, P ^f   Sullivan, P F ^a,d   Styner, M ^a   Gilmore, J H ^a   Knickmeyer, R C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g UNIVERSITY OF NEVADA   (United States)

^h UNIVERSITY OF FLORIDA   (United States)

ⁱ JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; AUTISM; BRAIN DEVELOPMENT; BRAIN SIZE; BRAIN TISSUE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GRAY MATTER; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NEWBORN; PHENOTYPE; PROTEIN EXPRESSION; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; WHITE MATTER; ANATOMY AND HISTOLOGY; BRAIN; DIAGNOSTIC IMAGING; GENETICS; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE;

INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-RELATED PROTEIN 1; SOMATOMEDIN BINDING PROTEIN;

BRAIN; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFANT; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MAGNETIC RESONANCE IMAGING; MALE; NEUROIMAGING; ORGAN SIZE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 85026775967     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2017.159     Document Type: Article

References (65)

1. Sullivan PF. The psychiatric GWAS consortium: big science comes to psychiatry. Neuron 2010; 68: 182-186.
2. Paus T. Population neuroscience: why and how. Hum Brain Mapp 2010; 31: 891-903.
3. Blokland GA, de Zubicaray GI, McMahon KL, Wright MJ. Genetic and environmental influences on neuroimaging phenotypes: A meta-analytical perspective on twin imaging studies. Twin Res Hum Genet 2012; 15: 351-371.
4. Strike LT, Couvy-Duchesne B, Hansell NK, Cuellar-Partida G, Medland SE, Wright MJ. Genetics and brain morphology. Neuropsychol Rev 2015; 25: 63-96.
5. van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry 2016; 21: 547-553.
6. Bois C, Whalley HC, McIntosh AM, Lawrie SM. Structural magnetic resonance imaging markers of susceptibility and transition to schizophrenia: A review of familial and clinical high risk population studies. J Psychopharmacol 2015; 29: 144-154.
7. Franke B, Stein JL, Ripke S, Anttila V, Hibar DP, van Hulzen KJ et al. Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof of concept. Nat Neurosci 2016; 19: 420-431.
8. Stein JL, Medland SE, Vasquez AA, Hibar DP, Senstad RE, Winkler AM et al. Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet 2012; 44: 552-561.
9. Fatemi SH, Folsom TD. The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr Bull 2009; 35: 528-548.
10. Chen JA, Penagarikano O, Belgard TG, Swarup V, Geschwind DH. The emerging picture of autism spectrum disorder: genetics and pathology. Annu Rev Pathol 2015; 10: 111-144.
11. Silbereis JC, Pochareddy S, Zhu Y, Li M, Sestan N. The cellular and molecular landscapes of the developing human central nervous system. Neuron 2016; 89: 248-268.
12. Birnbaum R, Jaffe AE, Chen Q, Hyde TM, Kleinman JE, Weinberger DR. Investigation of the prenatal expression patterns of 108 schizophrenia-associated genetic loci. Biol Psychiatry 2014; 77: e43-e51.
13. Wolff JJ, Gu H, Gerig G, Elison JT, Styner M, Gouttard S et al. Differences in white matter fiber tract development present from 6 to 24 months in infants with autism. Am J Psychiatry 2012; 169: 589-600.
14. Gilmore JH, Kang C, Evans DD, Wolfe HM, Smith JK, Lieberman JA et al. Prenatal and neonatal brain structure and white matter maturation in children at high risk for schizophrenia. Am J Psychiatry 2010; 167: 1083-1091.
15. Gilmore JH, Schmitt JE, Knickmeyer RC, Smith JK, Lin W, Styner M et al. Genetic and environmental contributions to neonatal brain structure: A twin study. Hum Brain Mapp 2010; 31: 1174-1182.
16. Prastawa M, Gilmore JH, Lin W, Gerig G. Automatic segmentation of MR images of the developing newborn brain. Med Image Anal 2005; 9: 457-466.
17. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904-909.
18. Liu EY, Li M, Wang W, Li Y. MaCH-admix: genotype imputation for admixed populations. Genet Epidemiol 2013; 37: 25-37.
19. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE et al. An integrated map of genetic variation from 1, 092 human genomes. Nature 2012; 491: 56-65.
20. Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA et al. A map of human genome variation from population-scale sequencing. Nature 2010; 467: 1061-1073.
21. Wright FA, Sullivan PF, Brooks AI, Zou F, Sun W, Xia K et al. Heritability and genomics of gene expression in peripheral blood. Nat Genet 2014; 46: 430-437.
22. Barsh GS, Copenhaver GP, Gibson G, Williams SM. Guidelines for genome-wide association studies. PLoS Genet 2012; 8: e1002812.
23. Reed E, Nunez S, Kulp D, Qian J, Reilly MP, Foulkes AS. A guide to genome-wide association analysis and post-analytic interrogation. Stat Med 2015; 34: 3769-3792.
24. Ghosh A, Zou F, Wright FA. Estimating odds ratios in genome scans: An approximate conditional likelihood approach. Am J Hum Genet 2008; 82: 1064-1074.
25. Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO et al. A global reference for human genetic variation. Nature 2015; 526: 68-74.
26. Birnbaum R, Jaffe AE, Hyde TM, Kleinman JE, Weinberger DR. Prenatal expression patterns of genes associated with neuropsychiatric disorders. Am J Psychiatry 2014; 171: 758-767.
27. Iyegbe C, Campbell D, Butler A, Ajnakina O, Sham P. The emerging molecular architecture of schizophrenia, polygenic risk scores and the clinical implications for GxE research. Soc Psychiatry Psychiatr Epidemiol 2014; 49: 169-182.
28. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748-752.
29. Colantuoni C, Lipska BK, Ye T, Hyde TM, Tao R, Leek JT et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 2011; 478: 519-523.
30. Kang HJ, Kawasawa YI, Cheng F, Zhu Y, Xu X, Li M et al. Spatio-temporal transcriptome of the human brain. Nature 2011; 478: 483-489.
31. Hibar DP, Stein JL, Renteria ME, Arias-Vasquez A, Desrivieres S, Jahanshad N et al. Common genetic variants influence human subcortical brain structures. Nature 2015; 520: 224-229.
32. Satterthwaite TD, Connolly JJ, Ruparel K, Calkins ME, Jackson C, Elliott MA et al. The Philadelphia Neurodevelopmental Cohort: A publicly available resource for the study of normal and abnormal brain development in youth. Neuroimage 2016; 124(Pt B): 1115-1119.
33. PGC. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511: 421-427.
34. PGC. Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis. Lancet 2013; 381: 1371-1379.
35. de Leeuw CA, Mooij JM, Heskes T, Posthuma D. MAGMA: generalized gene-set analysis of GWAS data. Plos Comput Biol 2015; 11: e1004219.
36. Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, Roussos P et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 2014; 506: 185-190.
37. Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 2014; 506: 179-184.
38. Kirov G, Pocklington AJ, Holmans P, Ivanov D, Ikeda M, Ruderfer D et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry 2012; 17: 142-153.
39. Darnell JC, Van Driesche SJ, Zhang C, Hung KY, Mele A, Fraser CE et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 2011; 146: 247-261.
40. Szatkiewicz JP, O'Dushlaine C, Chen G, Chambert K, Moran JL, Neale BM et al. Copy number variation in schizophrenia in Sweden. Mol Psychiatry 2014; 19: 762-773.
41. Iossifov I, Ronemus M, Levy D, Wang Z, Hakker I, Rosenbaum J et al. De novo gene disruptions in children on the autistic spectrum. Neuron 2012; 74: 285-299.
42. Ripke S, Neale BM, Corvin A, Walters JTR, Farh KH, Holmans PA et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511: 421-427.
43. Network and Pathway Analysis Subgroup of Psychiatric Genomics Consortium. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat Neurosci 2015; 18: 199-209.
44. Johnson DS, Mortazavi A, Myers RM, Wold B. Genome-wide mapping of in vivo protein-DNA interactions. Science 2007; 316: 1497-1502.
45. Weyn-Vanhentenryck SM, Mele A, Yan Q, Sun S, Farny N, Zhang Z et al. HITS-CLIP and integrative modeling define the Rbfox splicing-regulatory network linked to brain development and autism. Cell Rep 2014; 6: 1139-1152.
46. Szatkiewicz JP, Neale BM, O'Dushlaine C, Fromer M, Goldstein JI, Moran JL et al. Detecting large copy number variants using exome genotyping arrays in a large Swedish schizophrenia sample. Mol Psychiatry 2013; 18: 1178-1184.
47. Zarrei M, MacDonald JR, Merico D, Scherer SW. A copy number variation map of the human genome. Nat Rev Genet 2015; 16: 172-183.
48. Ikram MA, Fornage M, Smith AV, Seshadri S, Schmidt R, Debette S et al. Common variants at 6q22 and 17q21 are associated with intracranial volume. Nat Genet 2012; 44: 539-544.
49. Adams HH, Hibar DP, Chouraki V, Stein JL, Nyquist PA, Renteria ME et al. Novel genetic loci underlying human intracranial volume identified through genomewide association. Nat Neurosci 2016; 19: 1569-1582.
50. Short SJ, Elison JT, Goldman BD, Styner M, Gu H, Connelly M et al. Associations between white matter microstructure and infants' working memory. Neuroimage 2013; 64: 156-166.
51. Alcauter S, Lin W, Smith JK, Short SJ, Goldman BD, Reznick JS et al. Development of thalamocortical connectivity during infancy and its cognitive correlations. J Neurosci 2014; 34: 9067-9075.
52. Agis-Balboa RC, Arcos-Diaz D, Wittnam J, Govindarajan N, Blom K, Burkhardt S et al. A hippocampal insulin-growth factor 2 pathway regulates the extinction of fear memories. EMBO J 2011; 30: 4071-4083.
53. Loe-Mie Y, Lepagnol-Bestel AM, Maussion G, Doron-Faigenboim A, Imbeaud S, Delacroix H et al. SMARCA2 and other genome-wide supportedschizophrenia-associated genes: regulation by REST/NRSF, network organization and primate-specific evolution. Hum Mol Genet 2010; 19: 2841-2857.
54. Chiang MF, Chen ST, Lo CP, Sze CI, Chang NS, Chen YJ. Expression of WW domaincontaining oxidoreductase WOX1 in human nervous system tumors. Anal Cell Pathol 2013; 36: 133-147.
55. Bill BR, Lowe JK, Dybuncio CT, Fogel BL. Orchestration of neurodevelopmental programs by RBFOX1: implications for autism spectrum disorder. Int Rev Neurobiol 2013; 113: 251-267.
56. Stiles J, Jernigan TL. The basics of brain development. Neuropsychol Rev 2010; 20: 327-348.
57. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R et al. Functional impact of global rare copy number variation in autism spectrum conditions. Nature 466: 368-372.
58. Stone JL, O'Donovan MC, Gurling H, Kirov GK, Blackwood DHR, Corvin A et al. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008; 455: 237-241.
59. Minzenberg MJ, Laird AR, Thelen S, Carter CS, Glahn DC. Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Arch Gen Psychiatry 2009; 66: 811-822.
60. Goghari VM, Truong W, Spilka MJ. A magnetic resonance imaging family study of cortical thickness in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2015; 168: 660-668.
61. Zanetti MV, Schaufelberger MS, Doshi J, Ou Y, Ferreira LK, Menezes PR et al. Neuroanatomical pattern classification in a population-based sample of firstepisode schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2013; 43: 116-125.
62. Karlsgodt KH. Diffusion imaging of white matter in schizophrenia: progress and future directions. Biol Psychiatry Cogn Neurosci Neuroimaging 2016; 1: 209-217.
63. Bernhardt BC, Di Martino A, Valk SL, Wallace GL. Neuroimaging-based phenotyping of the autism spectrum. Curr Top Behav Neurosci 2016; 30: 341-355.
64. Wolff JJ, Piven J. Neurodevelopmental disorders: Accelerating progress in autism through developmental research. Nat Rev Neurol 2014; 10: 431-432.
65. Hazlett HC, Gu H, McKinstry RC, Shaw DW, Botteron KN, Dager SR et al. Brain volume findings in 6-month-old infants at high familial risk for autism. Am J Psychiatry 2012; 169: 601-608.